uniQure: Financials And Pipeline Signal A Promising Outlook For Investors (NASDAQ:QURE)

metamorworks

uniQure N.V. (NASDAQ:QURE), a trailblazing gene remedy agency, stands out as a compelling funding alternative poised to redefine the remedy panorama for numerous difficult illnesses. As the corporate has already demonstrated exceptional success with HEMGENIX for hemophilia Bdevelopment

Pipeline

www.uniqure.com/investors-media/events-presentations

Trial ABR

www.uniqure.com/investors-media/events-presentations

Percent Change inmHTT from Baseline

www.uniqure.com/investors-media/events-presentations

Mutations in SOD1

www.uniqure.com/investors-media/events-presentations

NfL Concentration in CSF

www.uniqure.com/investors-media/events-presentations

Back To Top